-
1
-
-
33748092560
-
Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on beta-lactam antibiotics: Insights from the Society of Infectious Diseases Pharmacists
-
Lodise TP Jr, Lomaestro BM, Drusano GL. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2006; 26:1320-32.
-
(2006)
Pharmacotherapy
, vol.26
, pp. 1320-1332
-
-
Lodise, T.P.1
Lomaestro, B.M.2
Drusano, G.L.3
-
2
-
-
0031952586
-
Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
-
Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998; 26:1-12.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1-12
-
-
Craig, W.A.1
-
3
-
-
0031856680
-
The pharmacodynamics of beta-lactams
-
Turnidge JD. The pharmacodynamics of beta-lactams. Clin Infect Dis. 1998; 27:10-22.
-
(1998)
Clin Infect Dis
, vol.27
, pp. 10-22
-
-
Turnidge, J.D.1
-
4
-
-
33845696211
-
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
-
Ambrose PG, Bhavnani SM, Rubino CM et al. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Clin Infect Dis. 2007; 44:79-86.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 79-86
-
-
Ambrose, P.G.1
Bhavnani, S.M.2
Rubino, C.M.3
-
5
-
-
0036239018
-
Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam
-
Kim MK, Capitano B, Mattoes HM et al. Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam. Pharmacotherapy. 2002; 22:569-77.
-
(2002)
Pharmacotherapy
, vol.22
, pp. 569-577
-
-
Kim, M.K.1
Capitano, B.2
Mattoes, H.M.3
-
6
-
-
33746353088
-
Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens
-
Scheetz MH, Hurt KM, Noskin GA et al. Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens. Am J Health-Syst Pharm. 2006; 63:1346-60.
-
(2006)
Am J Health-Syst Pharm
, vol.63
, pp. 1346-1360
-
-
Scheetz, M.H.1
Hurt, K.M.2
Noskin, G.A.3
-
7
-
-
70449732715
-
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients
-
Shea KM, Cheatham SC, Smith DW et al. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients. Ann Pharmacother. 2009; 43:1747-54.
-
(2009)
Ann Pharmacother
, vol.43
, pp. 1747-1754
-
-
Shea, K.M.1
Cheatham, S.C.2
Smith, D.W.3
-
8
-
-
11244334599
-
Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation
-
Lomaestro B, Drusano GL. Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation. Antimicrob Agents Chemother. 2005; 49:461-3.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 461-463
-
-
Lomaestro, B.1
Drusano, G.L.2
-
9
-
-
9644268224
-
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation
-
Lodise TP Jr, Lomaestro B, Rodvold KA et al. Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation. Antimicrob Agents Chemother. 2004; 48:4718-24.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 4718-4724
-
-
Lodise, T.P.1
Lomaestro, B.2
Rodvold, K.A.3
-
10
-
-
35848946597
-
Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: Prolonged or continuous infusion?
-
Kim A, Sutherland CA, Kuti JL et al. Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion? Pharmacotherapy. 2007; 27:1490-7.
-
(2007)
Pharmacotherapy
, vol.27
, pp. 1490-1497
-
-
Kim, A.1
Sutherland, C.A.2
Kuti, J.L.3
-
11
-
-
2142660223
-
Application of pharmacokinetics and pharmacodynamics to antibiotic selection
-
Ebert SC. Application of pharmacokinetics and pharmacodynamics to antibiotic selection. P&T. 2004; 29:244-53.
-
(2004)
P&T
, vol.29
, pp. 244-253
-
-
Ebert, S.C.1
-
12
-
-
78650276164
-
Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients
-
Cheatham SC, Shea KM, Healy DP et al. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients. Int J Antimicrob Agents. 2011; 37:46-50.
-
(2011)
Int J Antimicrob Agents
, vol.37
, pp. 46-50
-
-
Cheatham, S.C.1
Shea, K.M.2
Healy, D.P.3
-
13
-
-
33846442436
-
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: Clinical implications of an extended-infusion dosing strategy
-
Lodise TP Jr, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis. 2007; 44:357-63.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 357-363
-
-
Lodise, T.P.1
Lomaestro, B.2
Drusano, G.L.3
-
14
-
-
79961104396
-
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: A multicenter study
-
Yost RJ, Cappelletty DM, for the RECEIPT Study Group. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study. Pharmacotherapy. 2011; 31:767-75.
-
(2011)
Pharmacotherapy
, vol.31
, pp. 767-775
-
-
Yost, R.J.1
Cappelletty, D.M.2
-
15
-
-
60349101365
-
Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii
-
Letter
-
Wang D. Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents. 2009; 33:290-1. Letter.
-
(2009)
Int J Antimicrob Agents
, vol.33
, pp. 290-291
-
-
Wang, D.1
-
16
-
-
7444246084
-
Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts
-
Kotapati S, Nicolau DP, Nightingale CH et al. Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts. Am J Health-Syst Pharm. 2004; 61:1264-70.
-
(2004)
Am J Health-Syst Pharm
, vol.61
, pp. 1264-1270
-
-
Kotapati, S.1
Nicolau, D.P.2
Nightingale, C.H.3
-
17
-
-
55949093232
-
Trends in antibacterial use in US academic health centers
-
Pakyz AL, MacDougall C, Oinonen M et al. Trends in antibacterial use in US academic health centers. Arch Intern Med. 2008; 168:2254-60.
-
(2008)
Arch Intern Med
, vol.168
, pp. 2254-2260
-
-
Pakyz, A.L.1
MacDougall, C.2
Oinonen, M.3
-
19
-
-
0028208648
-
Compatibility of piperacillin sodium plus tazobactam sodium with selected drugs during simulated Y-site injection
-
Trissel LA, Martinez JF. Compatibility of piperacillin sodium plus tazobactam sodium with selected drugs during simulated Y-site injection. Am J Hosp Pharm. 1994; 51:672-8.
-
(1994)
Am J Hosp Pharm
, vol.51
, pp. 672-678
-
-
Trissel, L.A.1
Martinez, J.F.2
-
20
-
-
0032470573
-
Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration
-
Trissel LA, Gilbert DL. Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration. Hosp Pharm. 1998; 33:1515-22.
-
(1998)
Hosp Pharm
, vol.33
, pp. 1515-1522
-
-
Trissel, L.A.1
Gilbert, D.L.2
-
21
-
-
78049244903
-
Importance of infusion volume and pump characteristics in extended administration of beta-lactam antibiotics
-
Claus B, Buyle F, Robays H et al. Importance of infusion volume and pump characteristics in extended administration of beta-lactam antibiotics. Antimicrob Agents Chemother. 2010; 54:4950.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4950
-
-
Claus, B.1
Buyle, F.2
Robays, H.3
-
22
-
-
0017399410
-
Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets
-
Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.
-
(1977)
Am J Hosp Pharm
, vol.34
, pp. 939-943
-
-
Allen, L.V.1
Levinson, R.S.2
Phisutsinthop, D.3
-
23
-
-
84949151504
-
I.V. compatibility results
-
Greenwood Village, CO: Thomson Healthcare. Updated periodically
-
I.V. compatibility results. In: Micromedex Healthcare Series (Internet database). Greenwood Village, CO: Thomson Healthcare. Updated periodically.
-
Micromedex Healthcare Series (Internet Database)
-
-
-
24
-
-
44049095124
-
Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides
-
Desai NR, Shah SM, Cohen J et al. Zosyn (piperacillin/tazobactam) reformulation: expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides. Ther Clin Risk Manag. 2008; 4:303-14.
-
(2008)
Ther Clin Risk Manag
, vol.4
, pp. 303-314
-
-
Desai, N.R.1
Shah, S.M.2
Cohen, J.3
|